Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 553 of the 564 references it cites were found in a registry or an index.

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Open access
Luo, Zhen, Tian, Mingfu, Yang, Ge, Tan, Qiaoru, Chen, Yubing, Li, Geng, Zhang, Qiwei, Li, Yongkui, Wan, Pin, Wu, Jianguo · 2022 · Signal Transduction and Targeted Therapy

Abstract

Molecular oxygen (O 2 ) is essential for most biological reactions in mammalian cells. When the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is linked to several biological processes, including pathogenic microbe infection, metabolic adaptation, cancer, acute and chronic diseases, and other stress responses. The mechanism underlying cells respond to oxygen changes to mediate subsequent signal response is the central question during hypoxia. Hypoxia-inducible factors (HIFs) sense hypoxia to regulate the expressions of a series of downstream genes expression, which participate in multiple processes including cell metabolism, cell growth/death, cell proliferation, glycolysis, immune response, microbe infection, tumorigenesis, and metastasis. Importantly, hypoxia signaling also interacts with other cellular pathways, such as phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) signaling, nuclear factor kappa-B (NF-κB) pathway, extracellular signal-regulated kinases (ERK) signaling, and endoplasmic reticulum (ER) stress. This paper systematically reviews the mechanisms of hypoxia signaling activation, the control of HIF signaling, and the function of HIF signaling in human health and diseases. In addition, the therapeutic targets involved in HIF signaling to balance health and diseases are summarized and highlighted, which would provide novel strategies for the design and development of therapeutic drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-022-01080-1

Cites

553 of 553 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 History and events of the studies on hypoxia signaling. A glance of the discoverty and advance of the knownlegment of hypoxia signaling started from 1991. In 2019, the Nobel Prize in Physiology and Medicine was awarded for the discovery of cellular mechanisms for oxygen sensing in animals
Fig. 1 History and events of the studies on hypoxia signaling. A glance of the discoverty and advance of the knownlegment of hypoxia signaling started from 1991. In 2019, the Nobel Prize in Physiology and Medicine was awarded for the discovery of cellular mechanisms for oxygen sensing in animalsCC BY · PubMed Central
Fig. 2 The underlying principles of hypoxia and cross-talk of HIF signal with multiple pathways. a Under normoxia, HIFs (α and β subunits) undergo ubiquitination mediated by PHDs (oxygen-dependent proline hydroxylase family) and pVHL (von Hippel–Lindau tumor suppressor protein). The enzymatic activity PHD is prohibited under hypoxia. HIFs are stabilized to promote downstream genes transcription. b The interaction among HIF signal with multiple signaling pathways
Fig. 2 The underlying principles of hypoxia and cross-talk of HIF signal with multiple pathways. a Under normoxia, HIFs (α and β subunits) undergo ubiquitination mediated by PHDs (oxygen-dependent proline hydroxylase family) and pVHL (von Hippel–Lindau tumor suppressor protein). The enzymatic activity PHD is prohibited under hypoxia. HIFs are stabilized to promote downstream genes transcription. b The interaction among HIF signal with multiple signaling pathwaysCC BY · PubMed Central
Fig. 3 Biological functions of hypoxia signaling. Hypoxia signaling companied with the related genes participates in multiple biological processes
Fig. 3 Biological functions of hypoxia signaling. Hypoxia signaling companied with the related genes participates in multiple biological processesCC BY · PubMed Central
Fig. 4 Role of HIF-1α in hypixa signaling in COVID-19. When SARS-CoV-2 entering host cells, viral ORF3a protein induces HIF-1α expression through triggering mitochondrial reactive oxygen species (ROS) activation. The accumulated HIF-1α stimulates Ca2+ release, promotes viral replication and enhances glycolytic and inflammatory genes, which leads to a cytokine storm
Fig. 4 Role of HIF-1α in hypixa signaling in COVID-19. When SARS-CoV-2 entering host cells, viral ORF3a protein induces HIF-1α expression through triggering mitochondrial reactive oxygen species (ROS) activation. The accumulated HIF-1α stimulates Ca2+ release, promotes viral replication and enhances glycolytic and inflammatory genes, which leads to a cytokine stormCC BY · PubMed Central
Fig. 5 Summarized paticipation of HIF-1α in the tumorgenesis. The roles of HIF-1α in various kinds of human cancer. The tumorgenesis arises by the regulation of HIF-1α with intermediator and effectors such as indicated protein, miRNAs, or lncRNAs
Fig. 5 Summarized paticipation of HIF-1α in the tumorgenesis. The roles of HIF-1α in various kinds of human cancer. The tumorgenesis arises by the regulation of HIF-1α with intermediator and effectors such as indicated protein, miRNAs, or lncRNAsCC BY · PubMed Central
Fig. 6 Developed drugs targeting hypoxia signaling in human diseases. The main human diseases in different organs are displayed with the according the developed drugs targeting hypoxia signaling
Fig. 6 Developed drugs targeting hypoxia signaling in human diseases. The main human diseases in different organs are displayed with the according the developed drugs targeting hypoxia signalingCC BY · PubMed Central
Fig. 7 The principle of therapeutics targeting hypoxia signaling. The stratigies of therapeutics targeting hypoxia signaling are classified in (1) HIF-1α regulator; (2) Enzyme activity regulator; (3) deubiquinases regulator; (4) hypoxia-activated prodrug; and (5) P300 regulator
Fig. 7 The principle of therapeutics targeting hypoxia signaling. The stratigies of therapeutics targeting hypoxia signaling are classified in (1) HIF-1α regulator; (2) Enzyme activity regulator; (3) deubiquinases regulator; (4) hypoxia-activated prodrug; and (5) P300 regulatorCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 564 references

Research works printed but not linked: 1

  1. Wang, C., Han, C., Zhang, Y. & Liu, F. LncRNA PVT1 regulate expression of HIF1alpha via functioning as ceRNA for miR199a5p in nonsmall cell lung cancer under hypoxia. Mol. Med. Rep. 17, 1105–1110 (2018).

Cited by

See all 550

Metadata

Authors
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J.
Affiliations
  • Jinan University (CN)
  • The Affiliated Shunde Hospital of Jinan University (CN)
Corresponding author
  • Wan, Pin
  • Wu, Jianguo
Venue
Signal Transduction and Targeted Therapy
Published
2022-07-07
Volume
7
Issue
1
Pages
218-218
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4284690118
Cited by
499
References
564
Citations by year
2026: 139 · 2025: 171 · 2024: 123 · 2023: 60 · 2022: 6
FWCI
10.86
Type
journal article
Language
en
Open access
Licence
Locations
  • Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81730061, 32070148, 32100738)
  • China Postdoctoral Science Foundation (2021M691246)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
Keywords
hypoxia signaling, hypoxia-inducible factor, HIF signaling, oxygen sensing, cancer, metastasis, PI3K/mTOR signaling, NF-κB signaling, ERK signaling, endoplasmic reticulum stress, microbial infection, therapeutic target, drug development
MeSH terms
Hypoxia, Humans, Neoplasms, Oxygen, Signal Transduction, Phosphatidylinositol 3-Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. https://app.cochat.ai/papers/10.1038/s41392-022-01080-1
The paper
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022). Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-022-01080-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.